Illicit nicotine pouches on the rise in US, Altria CEO says
Send a link to a friend
[August 01, 2024]
(Reuters) - Marlboro maker Altria said on Wednesday it had sent
data to the U.S. Food and Drug Administration on growth in illegal
nicotine pouches, saying it echoed the early stages of a now massive
black market for vapes in the country.
Cigarette makers like Altria and British American Tobacco have lost
substantial U.S. sales to e-cigarettes that are being illegally marketed
without FDA authorization, including illegal disposable vapes from
China.
Altria said the supply chains supporting this market were enabling
illegal activity across multiple nicotine products, and it had
identified more than 350 unique illegal nicotine pouches on sale with
new brands launching every month.
"This illicit market echoes the beginning of the illicit e-vapor market
several years ago," Altria CEO William Gifford told analysts on a call
to discuss its second-quarter results, adding the company had shared
data on the issue with the FDA earlier this month.
"We believe it is critical that the FDA acts decisively to regain
control of the oral nicotine pouch category to prevent another
widespread illicit market from taking hold," he said.
The FDA did not immediately respond to a request for comment.
[to top of second column]
|
A woman poses with a cigarette in front of Altria logo in this
illustration taken July 26, 2022. REUTERS/Dado Ruvic/Illustration/File
Photo
Gifford said Altria had also
observed an increase in illicit cigarettes, one survey of discarded
packs in California finding that some 25% were non-U.S. brands,
mostly originating from duty-free channels or China, he said.
Earlier this month, analysts also warned Philip
Morris International's chief financial officer that they had
observed sales of its nicotine pouches intended for the Scandinavian
market on sale in the United States.
(Reporting by Emma Rumney in London and Juveria Tabassum in
Bengaluru; Editing by David Holmes)
[© 2024 Thomson Reuters. All rights reserved.]This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content. |